Company Update Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Alembic Pharmaceuticals Limited receives USFDA Final Approval for Bosutinib Tablets 100 mg and 500 mg